Cabergoline Effect on Blood Sugar in Type 2 Diabetics

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Mashhad University of Medical Sciences.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Haleh Rokni Yazdi, Mashhad University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01459601
First received: October 24, 2011
Last updated: NA
Last verified: October 2011
History: No changes posted

October 24, 2011
October 24, 2011
January 2012
February 2012   (final data collection date for primary outcome measure)
FBS (fasting blood sugar) [ Time Frame: 30days ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
HbA1C [ Time Frame: 30days ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Cabergoline Effect on Blood Sugar in Type 2 Diabetics
Cabergoline Effects on Blood Sugar Control in Type 2 Diabetics

Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Diabetes Type 2
Drug: Cabergoline
0,5mg per week
Other Name: Dastinex
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
10
February 2012
February 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Type 2 diabetes
  • HbA1C>7

Exclusion Criteria:

  • HbA1C>10
  • Psychiatric disorders
Both
Not Provided
No
Not Provided
 
NCT01459601
CabergolinDM
No
Haleh Rokni Yazdi, Mashhad University of Medical Sciences
Mashhad University of Medical Sciences
Not Provided
Not Provided
Mashhad University of Medical Sciences
October 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP